A human trial to evaluate the efficacy and safety of enzyme-treated Zizania latifolia (Griseb.) Turcz. ex Stapf extract powder on improvement of Liver functio
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0005510
- Lead Sponsor
- Wonkwang University Oriental Medical Hospital, Jeonju
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
1)Males and females aged over 19 years at the screening examination
2)Participants with 46 U/L=Alanine Transaminase(ALT), 65 U/L=Gamma-glutamyl transferase(GGT)
3)Participants who consume alcohol more than 14 unit/weeks for men and 7 unit/weeks for women
4)Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
1) GGT, ALT or AST > 3-fold of normal range
2) Individual with cirrosis, liver cancer or sign of liver cancer
3) Taking the liver function improving supplements or medicine within previous 1 month
4) Participation in other clinical trials within the previous 3 months
5) Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT(Alanine transaminase);GGT(Gamma-glutamyltransferase)
- Secondary Outcome Measures
Name Time Method liver function index;Lipids Metabolism index;steatosis index;Antioxidant index;MFS(Multidimensional Fatigue Scale)